title: Early stage triple negative and HER2 overexpression breast cancers have similar survivals in Chinese patients.
authors.forename: Qin
authors.initials: Q
authors.lastname: Zhang
authors.forename: Shou-Ching
authors.initials: SC
authors.lastname: Tang
authors.forename: Hong
authors.initials: H
authors.lastname: Liu
mesh_terms: D001943:Breast Neoplasms / Q000378:metabolism* / Q000401:mortality* / Q000473:pathology; D002681:China; D018572:Disease-Free Survival; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D009364:Neoplasm Recurrence, Local / Q000453:epidemiology; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000378:metabolism*; D011960:Receptors, Estrogen / Q000378:metabolism; D011980:Receptors, Progesterone / Q000378:metabolism; D015996:Survival Rate
chemical_list: D018719:Erb-b2 Receptor Tyrosine Kinases; D011960:Receptors, Estrogen; D011980:Receptors, Progesterone; C508053:ERBB2 protein, human